{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:54:20Z","timestamp":1789707260992,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["2017SGR1085"],"award-info":[{"award-number":["2017SGR1085"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["2017SGR1718"],"award-info":[{"award-number":["2017SGR1718"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM15\/00061"],"award-info":[{"award-number":["CM15\/00061"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ypmed.2020.106166","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T11:32:25Z","timestamp":1592479945000},"page":"106166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women"],"prefix":"10.1016","volume":"138","author":[{"given":"Maria","family":"Brotons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Monfil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Roura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita","family":"Duarte-Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Casabona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Urbiztondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"de Sanjos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2020.106166_bb0005","doi-asserted-by":"crossref","first-page":"f2032","DOI":"10.1136\/bmj.f2032","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","volume":"346","author":"Ali","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2020.106166_bb0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-13-140","article-title":"Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program","volume":"13","author":"Ali","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106166_bb0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/OLQ.0b013e31827bd66b","article-title":"Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program","volume":"40","author":"Baandrup","year":"2013","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.ypmed.2020.106166_bb0020","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","article-title":"Evidence of human papillomavirus vaccine-effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010","volume":"102","author":"Bauer","year":"2012","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ypmed.2020.106166_bb0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.medcli.2012.01.020","article-title":"SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research","volume":"138","author":"Bol\u00edbar","year":"2012","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.ypmed.2020.106166_bb0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/OLQ.0000000000000418","article-title":"Significant reduction in the incidence of genital warts in young men 5 years into the Danish Human Papillomavirus Vaccination Program for girls and women","volume":"43","author":"Bollerup","year":"2016","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.ypmed.2020.106166_bb0035","first-page":"137","article-title":"La vacunaci\u00f3 contra el virus del papil\u00b7loma hum\u00e0 a Catalunya: cobertures i notificacions de sospita de reaccions adverses a vacunes","volume":"36","author":"Borr\u00e0s-L\u00f3pez","year":"2017","journal-title":"Butll Epidemiol. Catalunya"},{"key":"10.1016\/j.ypmed.2020.106166_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/sextrans-2016-052626","article-title":"Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16\/18) vaccination programme in England: an ecological analysis","volume":"93","author":"Canvin","year":"2017","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.ypmed.2020.106166_bb0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/sextrans-2014-051813","article-title":"Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme","volume":"91","author":"Chow","year":"2015","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.ypmed.2020.106166_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12879-017-2361-5","article-title":"Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: an observational study","volume":"17","author":"Cocchio","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106166_bb0055","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2020.106166_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132404","article-title":"Evaluating the early benefit of quadrivalent HPV vaccine on genital warts in Belgium: a cohort study","volume":"10","author":"Dominiak-Felden","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ypmed.2020.106166_bb0065","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/infdis\/jix476","article-title":"The impact of human papillomavirus catch-up vaccination in Australia: implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation","volume":"216","author":"Drolet","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106166_bb0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2020.106166_bb0075","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2105\/AJPH.2017.304119","article-title":"Declines in anogenital warts among age groups most likely to be impacted by human papillomavirus vaccination, United States, 2006-2014","volume":"108","author":"Flagg","year":"2018","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ypmed.2020.106166_bb0080","first-page":"135","article-title":"Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP)","volume":"19","author":"Garc\u00eda-Gil","year":"2011","journal-title":"Inform. Prim. Care"},{"key":"10.1016\/j.ypmed.2020.106166_bb0085","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106166_bb0090","series-title":"Enquesta de Salut de Catalunya 2018. Principals indicadors ESCA2018","author":"Generalitat de Catalunya, Departament de Salut","year":"2019"},{"key":"10.1016\/j.ypmed.2020.106166_bb0095","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1016\/j.vaccine.2016.08.020","article-title":"Early impact of Ontario\u2019s human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): a population-based assessment","volume":"34","author":"Guerra","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2020.106166_bb0100","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/infdis\/jit361","article-title":"Declining genital warts in young women in England associated with HPV 16\/18 vaccination: an ecological study","volume":"208","author":"Howell-Jones","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106166_bb0105","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/infdis\/jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability","volume":"206","author":"Leval","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106166_bb0110","unstructured":"Ministerio de Sanidad, Consumo y Bienestar Social. Hist\u00f3rico de coberturas de vacunaci\u00f3n n.d. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/HistoricoCoberturas.htm (accessed May 2, 2020)."},{"key":"10.1016\/j.ypmed.2020.106166_bb0115","unstructured":"National Cancer Institute. Joinpoint. n.d."},{"key":"10.1016\/j.ypmed.2020.106166_bb0120","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/j.vaccine.2017.04.080","article-title":"Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain","volume":"35","author":"Navarro-Illana","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2020.106166_bb0125","first-page":"9","article-title":"Trends in genital warts diagnoses in New Zealand five years following the quadrivalent human papillomavirus vaccine introduction","volume":"130","author":"Oliphant","year":"2017","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.ypmed.2020.106166_bb0130","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1016\/j.vaccine.2015.09.071","article-title":"Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: population-based cross-sectional survey of Czech women aged 16 to 40 years","volume":"33","author":"Petr\u00e1\u0161","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2020.106166_bb0135","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.ejca.2015.06.001","article-title":"Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions","volume":"51","author":"Serrano","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ypmed.2020.106166_bb0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/infdis\/jiu370","article-title":"Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a National Human Papillomavirus Vaccination Program: analysis of routinely collected national hospital data","volume":"211","author":"Smith","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106166_bb0145","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12879-017-2663-7","article-title":"Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data","volume":"17","author":"Th\u00f6ne","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106166_bb0150","series-title":"Supply Division. Human Papillomavirus Vaccine Supply and Demand Update","author":"UNICEF","year":"2018"},{"key":"10.1016\/j.ypmed.2020.106166_bb0155","first-page":"550","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, October 2019: conclusions and recommendations","volume":"94","author":"WHO","year":"2019","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.ypmed.2020.106166_bb0160","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/j.vaccine.2017.05.069","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017-recommendations","volume":"35","author":"World Health Organization","year":"2017","journal-title":"Vaccine"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743520301900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743520301900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:06:21Z","timestamp":1777475181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743520301900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":32,"alternative-id":["S0091743520301900"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2020.106166","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2020.106166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106166"}}